XRP Sees Unprecedented 330% Growth in Fund Flows, Surpassing Solana

Another Week, Another Record Influx into Digital Asset Investment Introduction As the digital asset market continues to gain momentum, another CoinShares report has revealed that there was a staggering $1.3 billion in inflows into investment products in just one week. This marks the fifth consecutive week of substantial capital pouring into digital assets, highlighting the…

Read More

The Schall Law Firm Urges Shareholders with Losses to Join a Securities Class Action Lawsuit

The Schall Law Firm Reminds Investors of Class Action Lawsuit Against ModivCare Inc. Los Angeles, CA / ACCESS Newswire / January 30, 2025 The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ModivCare Inc. (“ModivCare” or “the Company”) (NASDAQ:MODV) for violations of §§10(b) and 20(a) of…

Read More

EyePoint Pharmaceuticals Announces Inducement Grants in Compliance with NASDAQ Listing Rule 5635C-4

EyePoint Pharmaceuticals Grants Inducement Awards to New Employees On February 17, 2025, EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a leading company in the development and commercialization of therapeutics for serious retinal diseases, announced the granting of non-statutory stock options to new employees. This announcement comes in accordance with NASDAQ Listing Rule 5635(c)(4), which allows for equity…

Read More

“Breaking News: ATIF Holdings Limited Secures $2.5 Million in Registered Direct and Private Placement!”

Exciting News for ATIF Holdings Limited ATIF Holdings Limited secures $2.5 million in funding Lake Forest, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) — ATIF Holdings Limited (Nasdaq: ZBAI) (the “Company”), a Lake Forest-based business consulting company that specializes in providing professional IPO, M&A advisory and post-IPO compliance services to small and medium-sized companies seeking to…

Read More

Regeneron Pharmaceuticals: Securities Lawsuit Alleges Violations Against the Biotech Giant

Understanding Your Options After Suffering a Loss on Regeneron Pharmaceuticals, Inc. (REGN) Investment If you have recently experienced a financial loss following an investment in Regeneron Pharmaceuticals, Inc. (REGN), you may be wondering if you have any recourse under federal securities laws. In such situations, it’s essential to be informed and take action if necessary….

Read More